John D. Gilly
CEO
PHARMACEUTICALS
OSI Pharmaceuticals Inc
United States of America
Biography
Recent projects that I have been involved with included a novel treatment that was efficacious to treat children with a rare cancer called neuroblastoma,” Dr. Gilly said. “Our program developed the agent that targeted the disease and supplied material to treat all children suffering from the disease in the United States until a company could assume responsibilities for production.
Research Interest
Pharmaceutical science